Seminar Title:” Drug-microbiome Interaction”
PBB 229
https://uconn-cmr.webex.com/meet/jem02027
Monday, March 4, 2024 from 12:20 pm – 1:10 pm
Dr. Andrew Goodman, PhD
C.N.H. Long Professor of Microbial pathogenesis and Director of Microbial Sciences Institute: Chair, Microbial Pathogenesis, ale School of Medicine
Andrew L. Goodman, PhD, is the C. N. H. Long Professor and Chair of the Department of Microbial Pathogenesis and Director of the Yale Microbial Sciences Institute. Goodman received his undergraduate degree in Ecology and Evolutionary Biology from Princeton University, his PhD in Microbiology and Molecular Genetics from Harvard University, and completed postdoctoral training at Washington University. His lab uses microbial genetics, gnotobiotics, and mass spectrometry to understand how gut microbes interact with their host during health and disease. The lab is also interested in how the microbiome impacts the efficacy and toxicity of medical drugs. The lab’s contributions have been recognized by the NIH Director New Innovator Award, the Pew Foundation, the Dupont Young Professors Award, the Burroughs Wellcome Foundation, the Howard Hughes Medical Institute Faculty Scholars Program, the ASPET John J. Abel Award, and the Presidential Early Career Award in Science and Engineering.
Education & Training
Washington University School of Medicine (2010)
Harvard Medical School (2006)
Princeton University, Ecology and Evolutionary Biology (1999)
For more information, contact: Deirdre McAvoy at deirdre.mcavoy@uconn.edu